Overview
No overview information available.
Background
No background information available.
Indication
本品为中等强度(中效)的镇痛药。用于偏头痛、神经性疼痛、炎症性疼痛、关节痛、外伤性疼痛、痛经、癌痛和术后疼痛，但对内脏器官的止痛作用较差。
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Bucinnazine Hydrochloride Injection | 国药准字H21023057 | 化学药品 | 注射剂 | 7/13/2020 | |
| Bucinnazine Hydrochloride Injection | 国药准字H12020966 | 化学药品 | 注射剂 | 7/20/2020 | |
| Bucinnazine Hydrochloride Injection | 国药准字H12020965 | 化学药品 | 注射剂 | 7/27/2020 | |
| Bucinnazine Hydrochloride Injection | 国药准字H21022365 | 化学药品 | 注射剂 | 7/13/2020 | |
| Bucinnazine Hydrochoride Tablets | 国药准字H12020159 | 化学药品 | 片剂 | 9/2/2020 | |
| Bucinnazine Hydrochoride Tablets | 国药准字H23020088 | 化学药品 | 片剂(素片) | 6/22/2020 | |
| Bucinnazine Hydrochoride Tablets | 国药准字H21021824 | 化学药品 | 片剂 | 5/12/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||